NO20080510L - Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon - Google Patents

Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon

Info

Publication number
NO20080510L
NO20080510L NO20080510A NO20080510A NO20080510L NO 20080510 L NO20080510 L NO 20080510L NO 20080510 A NO20080510 A NO 20080510A NO 20080510 A NO20080510 A NO 20080510A NO 20080510 L NO20080510 L NO 20080510L
Authority
NO
Norway
Prior art keywords
carcinoma
colorectal adenoma
colorectal
endoplasmin
biomarker
Prior art date
Application number
NO20080510A
Other languages
English (en)
Norwegian (no)
Inventor
Hartmut Juhl
Kerstin David
Anne-Kristin Fentz
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Publication of NO20080510L publication Critical patent/NO20080510L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
NO20080510A 2005-08-19 2008-01-28 Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon NO20080510L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/009005 WO2007019875A1 (en) 2005-08-19 2005-08-19 Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

Publications (1)

Publication Number Publication Date
NO20080510L true NO20080510L (no) 2008-05-19

Family

ID=36087694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080510A NO20080510L (no) 2005-08-19 2008-01-28 Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon

Country Status (13)

Country Link
US (1) US8580489B2 (de)
EP (1) EP1917530B1 (de)
JP (1) JP4832519B2 (de)
KR (1) KR101314959B1 (de)
AT (1) ATE499612T1 (de)
AU (1) AU2005335652A1 (de)
BR (1) BRPI0520483A2 (de)
CA (1) CA2617214C (de)
DE (1) DE602005026587D1 (de)
IL (1) IL189185A0 (de)
MX (1) MX2008001818A (de)
NO (1) NO20080510L (de)
WO (1) WO2007019875A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2126579A2 (de) * 2007-02-27 2009-12-02 Sentoclone AB Multiplex-nachweis von tumorzellen unter verwendung einer gruppe von an extrazelluläre marker bindenden agentien
CN109584961A (zh) * 2018-12-03 2019-04-05 元码基因科技（北京）股份有限公司 基于二代测序技术检测血液微卫星不稳定的方法
CN110244047B (zh) * 2019-06-10 2023-11-03 广州市妇女儿童医疗中心 肺癌血清诊断标志物及其应用、肺癌相关可溶性蛋白的分离鉴定方法
KR102735773B1 (ko) * 2022-11-10 2024-11-27 을지대학교 산학협력단 혈액 내 단백질 바이오마커를 포함하는 암 진단용 키트

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019967A1 (de) * 2000-04-20 2001-10-25 Fenning Biomed Gmbh Dr Antikörper gegen natives gp96, deren Herstellung und Verwendung
MXPA05006382A (es) 2002-12-20 2005-10-24 Hoffmann La Roche Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.
US8067152B2 (en) * 2006-02-27 2011-11-29 The Fred Hutchinson Cancer Research Center Liver cancer biomarkers

Also Published As

Publication number Publication date
US8580489B2 (en) 2013-11-12
EP1917530B1 (de) 2011-02-23
ATE499612T1 (de) 2011-03-15
WO2007019875A1 (en) 2007-02-22
BRPI0520483A2 (pt) 2009-11-10
CA2617214A1 (en) 2007-02-22
EP1917530A1 (de) 2008-05-07
KR101314959B1 (ko) 2013-10-11
CA2617214C (en) 2013-02-12
AU2005335652A1 (en) 2007-02-22
US20100273668A1 (en) 2010-10-28
DE602005026587D1 (de) 2011-04-07
KR20080036652A (ko) 2008-04-28
MX2008001818A (es) 2008-04-09
JP2009505080A (ja) 2009-02-05
JP4832519B2 (ja) 2011-12-07
IL189185A0 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
NO20070599L (no) Anvendelse av C3a og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt diagnosemetoder og testsytem som anvender samme.
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
WO2007112012A3 (en) Protein isoform discrimination and quantitative measurements thereof
DE60332639D1 (de) Verwendung von biomarkern zum nachweis von eierstockkrebs
MX2010007106A (es) Sistemas y metodos para el analisis de datos de pozos.
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
WO2005041893A3 (en) Detection of acute myocardial infarction biomarkers
MX2009000914A (es) Medios y metodos para evaluar el riesgo de intervenciones cardiacas basadas en el factor 15 de diferenciacion del crecimiento.
DE602007007209D1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
Segers et al. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes
NO20045473L (no) Fremgangsmate for a bestemme permeabiliteten til et undergrunnsmedium fra NMR-malinger av permeabiliteten til steinfragmenter fra mediet
GB201222576D0 (en) Method for diagnosing lung cancer
IL189185A0 (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2007035834A3 (en) Methods and systems for creating a recipe for a defect review process
WO2020165863A3 (en) Salivary biomarkers of brain injury
WO2014044791A3 (en) Methods and kits for predicting the sensitivity of a subject to chemotherapy
WO2012045324A8 (en) Method for detecting a parkinson's disease and test system
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
DE60332158D1 (de) Verfahren zur herzerkrankungsbewertung in einer einzelperson
WO2009078806A3 (en) Skeletal muscle proteome, muscle function and physical performance
ZA200801176B (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma ; method for detection and test system
EP1852513A3 (de) Verfahren zur Krebsdiagnose mittels Genmarker für krebsassoziierte Deletionen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application